Lake Forest, Illinois based Hospira acquired an active pharmaceutical ingredient (API) manufacturing facility and an associated research and development facility in Aurangabad from Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, for $218 million. "Hospira's acquisition of the 665 employee Orchid API facility will support supply continuity of...
Mylan buys Indian production unit from SMS Pharma for $33 million
India’s SMS Pharmaceuticals confirmed that it has sold its manufacturing units in Visakhapatnam, Andhra Pradesh, to U.S. generic drugmaker Mylan Laboratories for $33 million. The unit is makes bulk drugs and formulations for cancer treatment. The deal is the second Indian acquisition by Mylan after it acquired 71.5 % of ...
Hospira buys India R&D Center and Manufacturing Facility
Injectable generic drugs maker Hospira Inc said it plans to buy a factory and a research center from India-based Orchid Chemicals & Pharmaceuticals Ltd for $200 million. The factory, located in Aurangabad in India's western state of Maharashtra manufactures active pharmaceutical ingredients. It was constructed in 2000 and has 640...